Download
s41388-021-01781-x.pdf 2,31MB
WeightNameValue
1000 Titel
  • Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
1000 Autor/in
  1. Wanior, Marek |
  2. Krämer, Andreas |
  3. Knapp, Stefan |
  4. Joerger, Andreas |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-03
1000 Erschienen in
1000 Quellenangabe
  • 40(21):3637-3654
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41388-021-01781-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154588/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Multi-subunit ATPase-dependent chromatin remodelling complexes SWI/SNF (switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene transcription. Functional genomic studies revealed a remarkable mutation prevalence of SWI/SNF-encoding genes in 20-25% of all human cancers, frequently driving oncogenic programmes. Some SWI/SNF-mutant cancers are hypersensitive to perturbations in other SWI/SNF subunits, regulatory proteins and distinct biological pathways, often resulting in sustained anticancer effects and synthetic lethal interactions. Exploiting these vulnerabilities is a promising therapeutic strategy. Here, we review the importance of SWI/SNF chromatin remodellers in gene regulation as well as mechanisms leading to assembly defects and their role in cancer development. We will focus in particular on emerging strategies for the targeted therapy of SWI/SNF-deficient cancers using chemical probes, including proteolysis targeting chimeras, to induce synthetic lethality.
1000 Sacherschließung
lokal Chromatin Assembly and Disassembly [MeSH]
lokal Target validation
lokal Target identification
lokal Transcription Factors/genetics [MeSH]
lokal Chromosomal Proteins, Non-Histone/antagonists
lokal Humans [MeSH]
lokal Review Article
lokal Antineoplastic Agents/pharmacology [MeSH]
lokal Neoplasms/genetics [MeSH]
lokal Animals [MeSH]
lokal Neoplasms/metabolism [MeSH]
lokal Neoplasms/pathology [MeSH]
lokal Epigenetics
lokal Neoplasms/drug therapy [MeSH]
lokal Targeted therapies
lokal Transcription Factors/metabolism [MeSH]
lokal Chromatin remodelling
lokal Carcinogenesis [MeSH]
lokal Epigenomics [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-9569-4487|https://orcid.org/0000-0003-3294-2660|https://orcid.org/0000-0001-5995-6494|https://orcid.org/0000-0002-1232-0138
1000 Hinweis
  • DeepGreen-ID: 22d2451fb4144c02a8e0e8bc98ab2c0b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443696.rdf
1000 Erstellt am 2023-04-27T10:24:10.638+0200
1000 Erstellt von 322
1000 beschreibt frl:6443696
1000 Zuletzt bearbeitet 2023-10-19T15:25:24.515+0200
1000 Objekt bearb. Thu Oct 19 15:25:24 CEST 2023
1000 Vgl. frl:6443696
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443696 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source